Episodes 31-45 of 160
IgA Nephropathy Care: Ensuring Timely Detection and Intervention
Clinician's RoundtableIgA Nephropathy Care: Ensuring Timely Detection and Intervention
Examining Key Factors in IgAN: The Role of B Cells and BAFF/APRIL
Clinician's RoundtableExamining Key Factors in IgAN: The Role of B Cells and BAFF/APRIL
Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
Project Oncology®Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
Osteoporosis in CKD: Closing the Gaps in Diagnosis and Treatment
On the Frontlines of OsteoporosisOsteoporosis in CKD: Closing the Gaps in Diagnosis and Treatment
Topline Results of the CONFIDENCE Trial
DataPulse: Focus on the Latest Updates on Non-Steroidal MRAs in Patients with Heart Failure (HFmrEF/HFpEF)Topline Results of the CONFIDENCE Trial
The CONFIDENCE Trial: Data Insights
DataPulse: Key Clinical Trial Insights on Nonsteroidal MRAs in CKM Syndrome ManagementThe CONFIDENCE Trial: Data Insights
- advertisement
Impact of Finerenone on eGFR Slope by Baseline Albuminuria in FINEARTS-HF
DataPulse: Focus on the Latest Updates on Non-Steroidal MRAs in Patients with Heart Failure (HFmrEF/HFpEF)Impact of Finerenone on eGFR Slope by Baseline Albuminuria in FINEARTS-HF
Albuminuria Change and Finerenone's Effect on CV Outcomes
DataPulse: Focus on the Latest Updates on Non-Steroidal MRAs in Patients with Heart Failure (HFmrEF/HFpEF)Albuminuria Change and Finerenone's Effect on CV Outcomes
TILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Project Oncology®TILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Novel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Broadcast ReplayNovel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Optimizing C3G Management: The Power of Lifestyle Changes and Supportive Care
On the Frontlines of C3GOptimizing C3G Management: The Power of Lifestyle Changes and Supportive Care
Patient Counseling in C3GN: From Disease Education to Shared Decision-Making
On the Frontlines of C3GPatient Counseling in C3GN: From Disease Education to Shared Decision-Making
- advertisement
Challenges in C3GN Care: Managing Relapsing and Treatment-Resistant Disease
On the Frontlines of C3GChallenges in C3GN Care: Managing Relapsing and Treatment-Resistant Disease
Advancing C3G Care with the Approval of a Complement Factor B Inhibitor
On the Frontlines of C3GAdvancing C3G Care with the Approval of a Complement Factor B Inhibitor
Enhancing Lupus Nephritis Outcomes: The Potential Impact of Lower Glucocorticoid Doses
Living RheumEnhancing Lupus Nephritis Outcomes: The Potential Impact of Lower Glucocorticoid Doses
